BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19723758)

  • 1. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
    Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
    Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
    Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omentin-1, visfatin and adiponectin levels in relation to bone mineral density in Iranian postmenopausal women.
    Tohidi M; Akbarzadeh S; Larijani B; Kalantarhormozi M; Ostovar A; Assadi M; Vahdat K; Farrokhnia M; Sanjdideh Z; Amirinejad R; Nabipour I
    Bone; 2012 Nov; 51(5):876-81. PubMed ID: 22971441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
    Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome.
    Iacobellis G; Iorio M; Napoli N; Cotesta D; Zinnamosca L; Marinelli C; Petramala L; Minisola S; D'Erasmo E; Letizia C
    J Endocrinol Invest; 2011 Jan; 34(1):e12-5. PubMed ID: 20634640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metabolism and body composition in Japanese patients with active acromegaly.
    Kaji H; Sugimoto T; Nakaoka D; Okimura Y; Kaji H; Abe H; Chihara K
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):175-81. PubMed ID: 11531923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
    Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females.
    Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Farrerons J; Lluch P; Puig T; Wägner AM; Ricart W; Webb SM
    Eur J Endocrinol; 2008 Dec; 159(6):773-9. PubMed ID: 18805912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations.
    Stadler M; Storka A; Theuer EA; Krebs M; Vojtassakova E; Nowotny P; Pacini G; Kästenbauer T; Luger A; Prager R; Wolzt M; Anderwald C
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):763-9. PubMed ID: 19769621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly.
    Piskinpasa H; Okuturlar Y; Dogansen SC; Akdeniz YS; Esen A; Sadri S; Pirhan O; Gemici AA; Serin SO; Gedikbası A; Adas M; Mert M
    Horm Metab Res; 2019 Oct; 51(10):649-654. PubMed ID: 31487747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations.
    Ciresi A; Amato MC; Pizzolanti G; Giordano C
    Growth Horm IGF Res; 2015 Oct; 25(5):240-6. PubMed ID: 26188992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating cytokines in relation to bone mineral density changes in patients with acromegaly.
    Bolanowski M; Daroszewski J; Zatonska K; Arkowska A
    Neuro Endocrinol Lett; 2006; 27(1-2):183-8. PubMed ID: 16648806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men.
    Gonnelli S; Caffarelli C; Del Santo K; Cadirni A; Guerriero C; Lucani B; Franci B; Nuti R
    Calcif Tissue Int; 2008 Jul; 83(1):55-60. PubMed ID: 18563283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa.
    Misra M; Miller KK; Cord J; Prabhakaran R; Herzog DB; Goldstein M; Katzman DK; Klibanski A
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2046-52. PubMed ID: 17356044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients.
    Chen L; Liu W; Lai S; Li Y; Wang X; Zhang H
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):935-41. PubMed ID: 23470357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
    Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
    Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women.
    Zhang H; Xie H; Zhao Q; Xie GQ; Wu XP; Liao EY; Luo XH
    J Endocrinol Invest; 2010 Nov; 33(10):707-11. PubMed ID: 20208458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
    Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
    Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.